Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Epilepsy

  Free Subscription


Articles published in Eur J Clin Pharmacol

Retrieve available abstracts of 11 articles:
HTML format
Text format



Single Articles


    April 2017
  1. BAFTIU A, Landmark CJ, Rusten IR, Feet SA, et al
    Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-A pharmacoepidemiological study and clinical implications.
    Eur J Clin Pharmacol. 2017 Apr 7. doi: 10.1007/s00228-017-2252.
    PubMed     Text format    


    March 2017
  2. SCHOEMAKER R, Wade JR, Stockis A
    Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
    Eur J Clin Pharmacol. 2017 Mar 9. doi: 10.1007/s00228-017-2230.
    PubMed     Text format     Abstract available


    February 2017
  3. PUTIGNANO D, Clavenna A, Campi R, Bortolotti A, et al
    Antiepileptic drug use in Italian children over a decade.
    Eur J Clin Pharmacol. 2017;73:241-248.
    PubMed     Text format     Abstract available


    January 2017
  4. ZHANG ZB, Ji SM, Han Y, Zang LL, et al
    Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.
    Eur J Clin Pharmacol. 2017 Jan 7. doi: 10.1007/s00228-016-2190.
    PubMed     Text format     Abstract available


    November 2016
  5. LU Y, Fang Y, Wu X, Ma C, et al
    Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Eur J Clin Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  6. BAFTIU A, Johannessen Landmark C, Rusten IR, Feet SA, et al
    Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.
    Eur J Clin Pharmacol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  7. SIGAROUDI A, Kullak-Ublick GA, Weiler S
    Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.
    Eur J Clin Pharmacol. 2016;72:377-8.
    PubMed     Text format    


    January 2016
  8. INOUE K, Yamamoto Y, Suzuki E, Takahashi T, et al
    Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
    Eur J Clin Pharmacol. 2016.
    PubMed     Text format     Abstract available


  9. DJORDJEVIC N, Milovanovic DD, Radovanovic M, Radosavljevic I, et al
    CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.
    Eur J Clin Pharmacol. 2016.
    PubMed     Text format     Abstract available


    August 2015
  10. LIU L, Zhao L, Wang Q, Qiu F, et al
    Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
    Eur J Clin Pharmacol. 2015.
    PubMed     Text format     Abstract available


    October 2014
  11. YAMAMOTO Y, Takahashi Y, Imai K, Takahashi M, et al
    Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy.
    Eur J Clin Pharmacol. 2014;70:1203-10.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: